KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $91000.0.

  • Staar Surgical's Exchange Rate Effect fell 9122.47% to $91000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $182000.0, marking a year-over-year decrease of 7147.34%. This contributed to the annual value of -$1.1 million for FY2024, which is 65000.0% down from last year.
  • Latest data reveals that Staar Surgical reported Exchange Rate Effect of $91000.0 as of Q3 2025, which was down 9122.47% from $686000.0 recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Exchange Rate Effect registered a high of $1.0 million during Q3 2024, and its lowest value of -$937000.0 during Q1 2024.
  • In the last 5 years, Staar Surgical's Exchange Rate Effect had a median value of -$94500.0 in 2021 and averaged -$70100.0.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first skyrocketed by 68872.18% in 2022, then tumbled by 947000.0% in 2024.
  • Staar Surgical's Exchange Rate Effect (Quarter) stood at -$133000.0 in 2021, then soared by 688.72% to $783000.0 in 2022, then rose by 10.86% to $868000.0 in 2023, then crashed by 201.5% to -$881000.0 in 2024, then skyrocketed by 110.33% to $91000.0 in 2025.
  • Its Exchange Rate Effect stands at $91000.0 for Q3 2025, versus $686000.0 for Q2 2025 and $286000.0 for Q1 2025.